-+ 0.00%
-+ 0.00%
-+ 0.00%

VISTAGEN THERAPEUTICS - FDA RECOGNIZES FASEDIENOL'S REPORTED SAFETY PROFILE AND POTENTIAL BENEFIT FOR SAD PATIENTS

Reuters·11/09/2026 13:30:03

Please log in to view news